Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Assets Average (2016 - 2025)

Fennec Pharmaceuticals filings provide 15 years of Assets Average readings, the most recent being $59.9 million for Q4 2025.

  • On a quarterly basis, Assets Average rose 15.35% to $59.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $59.9 million, a 15.35% increase, with the full-year FY2025 number at $57.7 million, up 60.84% from a year prior.
  • Assets Average hit $59.9 million in Q4 2025 for Fennec Pharmaceuticals, up from $47.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $66.2 million in Q2 2024 to a low of $17.4 million in Q2 2022.
  • Median Assets Average over the past 5 years was $28.3 million (2021), compared with a mean of $35.6 million.
  • Biggest five-year swings in Assets Average: plummeted 37.94% in 2022 and later surged 220.8% in 2024.
  • Fennec Pharmaceuticals' Assets Average stood at $24.2 million in 2021, then grew by 18.44% to $28.7 million in 2022, then dropped by 18.33% to $23.4 million in 2023, then surged by 121.74% to $51.9 million in 2024, then grew by 15.35% to $59.9 million in 2025.
  • The last three reported values for Assets Average were $59.9 million (Q4 2025), $47.1 million (Q3 2025), and $45.6 million (Q2 2025) per Business Quant data.